Chinese gene therapy drug startup OBiO recently announced that it has completed a series C financing of over RMB300 million yuan. This round of financing is led by Loyal Valley Capital, with participation from Morningside Group, Lingang Technology Venture Capital, Sherpa Capital, and Kunlun Capital , Gimpo National Research and Investment, and Boyuan Capital. This […]
Gene Therapy Drug Startup OBiO Raises RMB300 Million comes from China Money Network: Primary Data for China’s Primary Markets! All Rights Reserved.